16-84191243-T-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000315906.10(ADAD2):āc.13T>Gā(p.Ser5Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,607,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
ENST00000315906.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAD2 | NM_001145400.2 | c.13T>G | p.Ser5Ala | missense_variant | 1/10 | ENST00000315906.10 | NP_001138872.1 | |
ADAD2 | NM_139174.4 | c.13T>G | p.Ser5Ala | missense_variant | 1/11 | NP_631913.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAD2 | ENST00000315906.10 | c.13T>G | p.Ser5Ala | missense_variant | 1/10 | 1 | NM_001145400.2 | ENSP00000325153 | P1 | |
ADAD2 | ENST00000268624.7 | c.13T>G | p.Ser5Ala | missense_variant | 1/11 | 2 | ENSP00000268624 | |||
ADAD2 | ENST00000567413.1 | n.53T>G | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.00000424 AC: 1AN: 235632Hom.: 0 AF XY: 0.00000771 AC XY: 1AN XY: 129658
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1455570Hom.: 0 Cov.: 88 AF XY: 0.0000152 AC XY: 11AN XY: 723370
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 35 AF XY: 0.0000134 AC XY: 1AN XY: 74356
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at